Pub Date : 2025-12-01Epub Date: 2025-10-27DOI: 10.1016/j.ancard.2025.101959
H. Bensussan , R. Auger , T. Genet , A. Bernard
This case report tells the story of a non-trivial infarction, where the usual rapid management of a ST-segment elevation infarction could have led to serious consequences for the patient. It is important to maintain a systematic clinical assessment before performing invasive procedures.
{"title":"Infarctus du myocarde inférieur avec extension au ventricule droit lié à un énorme thrombus naissant de l’aorte ascendante et envahissant la coronaire droite – cas clinique","authors":"H. Bensussan , R. Auger , T. Genet , A. Bernard","doi":"10.1016/j.ancard.2025.101959","DOIUrl":"10.1016/j.ancard.2025.101959","url":null,"abstract":"<div><div>This case report tells the story of a non-trivial infarction, where the usual rapid management of a ST-segment elevation infarction could have led to serious consequences for the patient. It is important to maintain a systematic clinical assessment before performing invasive procedures.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101959"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145386023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-10-27DOI: 10.1016/j.ancard.2025.101958
Imène Rachdi, Mariem Ben Brahim, Mehdi Somai, Ibrahim Arbaoui, Besma Ben Dhaou, Fatma Boussema, Fatma Daoud, Zohra Aydi
Background
Vitamin K antagonists (VKAs) are the most commonly prescribed drug for the treatment of venous thromboembolism (VTE). Our study’s aim was to evaluate the role of Time in Therapeutic Range (TTR) in preventing thrombotic and hemorrhagic complications in patients treated by VKAs for VTE.
The mean age of patients was 59.4 ± 16.7 years. Sex-ratio was 1.5. VKAs were mainly prescribed for deep venous thromboses (57%). Cancer was the most common etiology (26%). The mean follow-up period was 5.3 months. The mean TTR was 36.1±22.5%. Twenty-seven percent of patients had a TTR>50%. We noted 25% of hemorrhagic events and 15% of thromboembolic recurrence. A TTR<50% was correlated with hemorrhagic complications (p=0.02), but not with thrombotic ones (p = 0.224).
Conclusion
Our results outline the necessity of implementing adequate tools to improve anticoagulation in our population. Implementing TTR as a quality assessment tool for anticoagulation will likely decrease complications related to VKAs.
Pub Date : 2025-12-01Epub Date: 2025-07-05DOI: 10.1016/j.ancard.2025.101903
Alexia François , Eddy Ngando Ngena , Laurence Van Der Haert , Emmanuel Haine , Linda Kubangumusu Bunzi
Takotsubo syndrome (TTS), also known as “stress cardiomyopathy”, manifests as transient left ventricular dysfunction and shares similarities with acute coronary syndrome (ACS). Although often considered benign, it has mortality rates and complications (cardiogenic shock, arrhythmias, etc.) close to those of ACS.
This article reports on a clinical case of Takotsubo syndrome in a 70-year-old female patient who presented a series of complications. This serves as a reminder of the need for intensive follow-up during the acute phase.
{"title":"Complications successives dans le syndrome de takotsubo – de l'oedème pulmonaire au choc cardiogénique aigu à l'arythmie ventriculaire : un rapport de cas","authors":"Alexia François , Eddy Ngando Ngena , Laurence Van Der Haert , Emmanuel Haine , Linda Kubangumusu Bunzi","doi":"10.1016/j.ancard.2025.101903","DOIUrl":"10.1016/j.ancard.2025.101903","url":null,"abstract":"<div><div>Takotsubo syndrome (TTS), also known as “stress cardiomyopathy”, manifests as transient left ventricular dysfunction and shares similarities with acute coronary syndrome (ACS). Although often considered benign, it has mortality rates and complications (cardiogenic shock, arrhythmias, etc.) close to those of ACS.</div><div>This article reports on a clinical case of Takotsubo syndrome in a 70-year-old female patient who presented a series of complications. This serves as a reminder of the need for intensive follow-up during the acute phase.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101903"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144563892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-14DOI: 10.1016/S0003-3928(25)00131-3
{"title":"Sommaire","authors":"","doi":"10.1016/S0003-3928(25)00131-3","DOIUrl":"10.1016/S0003-3928(25)00131-3","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101992"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aim of this study was to analyze the management of atrial fibrillation in a cardiology department in sub-Saharan Africa.
Methodology and results
We conducted a retrospective study of 146 consecutive patients aged at least 18 years hospitalized for atrial fibrillation over a two-year period in our cardiology department at the cardiology institute of Abidjan (Côte d'Ivoire). The mean age of the study population was 61.2 ±15.5 years, and the majority were women (51.4%). The respective prevalences of paroxysmal, persistent, and permanent fibrillation were 11.6%, 4.1%, and 32.2%.
The underlying pathologies found in 105 patients were: hypertensive heart disease (47.2%), valvular heart disease (15.7%), and dilated cardiomyopathy (4.1%). A heart rate control strategy was chosen in the majority of cases (84.2%). Beta-blockers (36.3%), digoxin (20.5%), and amiodarone (18%) were the most commonly used drug classes. The mean CHA2DS2VASc score was 3±1.57, and 85.2% of patients had a CHA2DS2VASc score ≥ 2. Of the patients requiring oral anticoagulation, 91 (76.5%) received it.
Conclusion
Atrial fibrillation is severe in our context because of the greater prevalence of heart failure, hypertensive heart disease and cardiovascular risk factors, all of which increase the risk of thromboembolism. The heart rate control strategy was predominant and oral anticoagulation was correctly prescribed in 76.5% despite a high CHA2DS2VASc score.
{"title":"Analyse rétrospective de la prise en charge de la fibrillation atriale dans un service de cardiologie à l’Institut de Cardiologie d’Abidjan (Côte d’Ivoire)","authors":"Iklo Coulibaly , Marie-Paule Bernadette N'cho-Mottoh , Florent Kouassi Koffi , Inès Angoran , Fatoumata Traoré , Stéphane Youmbi Simeu","doi":"10.1016/j.ancard.2025.101904","DOIUrl":"10.1016/j.ancard.2025.101904","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to analyze the management of atrial fibrillation in a cardiology department in sub-Saharan Africa.</div></div><div><h3>Methodology and results</h3><div>We conducted a retrospective study of 146 consecutive patients aged at least 18 years hospitalized for atrial fibrillation over a two-year period in our cardiology department at the cardiology institute of Abidjan (Côte d'Ivoire). The mean age of the study population was 61.2 ±15.5 years, and the majority were women (51.4%). The respective prevalences of paroxysmal, persistent, and permanent fibrillation were 11.6%, 4.1%, and 32.2%.</div><div>The underlying pathologies found in 105 patients were: hypertensive heart disease (47.2%), valvular heart disease (15.7%), and dilated cardiomyopathy (4.1%). A heart rate control strategy was chosen in the majority of cases (84.2%). Beta-blockers (36.3%), digoxin (20.5%), and amiodarone (18%) were the most commonly used drug classes. The mean CHA2DS2VASc score was 3±1.57, and 85.2% of patients had a CHA2DS2VASc score ≥ 2. Of the patients requiring oral anticoagulation, 91 (76.5%) received it.</div></div><div><h3>Conclusion</h3><div>Atrial fibrillation is severe in our context because of the greater prevalence of heart failure, hypertensive heart disease and cardiovascular risk factors, all of which increase the risk of thromboembolism. The heart rate control strategy was predominant and oral anticoagulation was correctly prescribed in 76.5% despite a high CHA2DS2VASc score.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101904"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular mortality worldwide, following stroke and myocardial infarction. Rituximab, a monoclonal antibody targeting CD20 on B lymphocytes, is increasingly used in the management of autoimmune conditions. While generally well tolerated, rare thromboembolic events have been reported. The pathophysiological mechanisms remain unclear but may involve endothelial dysfunction, cytokine release, or immune-mediated vascular injury.
We report the case of a 56-year-old woman with bullous pemphigoid treated with rituximab, who developed extensive thromboembolic complications. The patient presented with acute dyspnea and leg pain. Clinical evaluation and imaging confirmed the diagnosis of DVT and PE. No predisposing factors such as recent surgery, immobilization, or malignancy were identified. The temporal relationship with rituximab infusion suggested a possible causal link. Anticoagulation was initiated, and rituximab therapy was discontinued. The aim of this report is to underscore the possible thromboembolic risk related to rituximab, and to discuss the underlying pathophysiological mechanisms, contributing risk factors, and strategies for prevention and clinical management.
{"title":"Thromboembolic complications following rituximab therapy in a patient with bullous pemphigoid : A case report","authors":"Nouhaila Wakil, Lamia Tlohi, Meryem Haboub, Rachida Habbal","doi":"10.1016/j.ancard.2025.101957","DOIUrl":"10.1016/j.ancard.2025.101957","url":null,"abstract":"<div><div>Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular mortality worldwide, following stroke and myocardial infarction. Rituximab, a monoclonal antibody targeting CD20 on B lymphocytes, is increasingly used in the management of autoimmune conditions. While generally well tolerated, rare thromboembolic events have been reported. The pathophysiological mechanisms remain unclear but may involve endothelial dysfunction, cytokine release, or immune-mediated vascular injury.</div><div>We report the case of a 56-year-old woman with bullous pemphigoid treated with rituximab, who developed extensive thromboembolic complications. The patient presented with acute dyspnea and leg pain. Clinical evaluation and imaging confirmed the diagnosis of DVT and PE. No predisposing factors such as recent surgery, immobilization, or malignancy were identified. The temporal relationship with rituximab infusion suggested a possible causal link. Anticoagulation was initiated, and rituximab therapy was discontinued. The aim of this report is to underscore the possible thromboembolic risk related to rituximab, and to discuss the underlying pathophysiological mechanisms, contributing risk factors, and strategies for prevention and clinical management.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101957"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145386017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-07DOI: 10.1016/j.ancard.2025.101914
Mohamed Issa Elkharchi , Sidi Mohamed Cheikh Limame , Sidi M’hamed Ethmane , Salihou Fall , Mohamed Ahmedou Seyid , Mohamed Abdallahi Memahi , Mahfoudh Mohamed Taleb , Sirakhé Camara , Ahmed Eba , Horma Zein
Introduction
Acute heart failure is a major public health issue worldwide. However, its characteristics in Mauritania remain unknown.
Objective
The aim of our study is to assess the characteristics of acute heart failure in Mauritania.
Methods
We conducted a single-center, prospective, observational, and descriptive study. We included patients hospitalized for acute heart failure at the National Cardiology Center between January 1, 2024, and May 31, 2024.
Results
During the study period, 307 patients were hospitalized for acute heart failure. The mean age of patients was 59.8 ± 15 years, with men accounting for 64.8%. The main cardiovascular risk factor was hypertension (31.6%). NYHA stages 3 and 4 represented 12.7% and 73.6%, respectively. Atrial fibrillation was present in 23.1% of cases, and anemia was found in 51.8%. The mean left ventricular ejection fraction was 41.6%. Decompensated chronic heart failure was the most common presentation (37.8%), while heart failure with reduced ejection fraction accounted for 55.7%. Ischemic heart disease was present in 33.2% of cases. Quadruple therapy for heart failure was initiated in the majority of patients before hospital discharge. The in-hospital mortality rate was 5.5%.
Conclusion
Acute heart failure in Mauritania primarily affects middle-aged individuals. The care follows the guidelines in the National Cardiology Center. A significant effort must be made to extend this organization to the rest of the country.
{"title":"Résultats hospitaliers du registre de l'insuffisance cardiaque aiguë en mauritanie","authors":"Mohamed Issa Elkharchi , Sidi Mohamed Cheikh Limame , Sidi M’hamed Ethmane , Salihou Fall , Mohamed Ahmedou Seyid , Mohamed Abdallahi Memahi , Mahfoudh Mohamed Taleb , Sirakhé Camara , Ahmed Eba , Horma Zein","doi":"10.1016/j.ancard.2025.101914","DOIUrl":"10.1016/j.ancard.2025.101914","url":null,"abstract":"<div><h3>Introduction</h3><div>Acute heart failure is a major public health issue worldwide. However, its characteristics in Mauritania remain unknown.</div></div><div><h3>Objective</h3><div>The aim of our study is to assess the characteristics of acute heart failure in Mauritania.</div></div><div><h3>Methods</h3><div>We conducted a single-center, prospective, observational, and descriptive study. We included patients hospitalized for acute heart failure at the National Cardiology Center between January 1, 2024, and May 31, 2024.</div></div><div><h3>Results</h3><div>During the study period, 307 patients were hospitalized for acute heart failure. The mean age of patients was 59.8 ± 15 years, with men accounting for 64.8%. The main cardiovascular risk factor was hypertension (31.6%). NYHA stages 3 and 4 represented 12.7% and 73.6%, respectively. Atrial fibrillation was present in 23.1% of cases, and anemia was found in 51.8%. The mean left ventricular ejection fraction was 41.6%. Decompensated chronic heart failure was the most common presentation (37.8%), while heart failure with reduced ejection fraction accounted for 55.7%. Ischemic heart disease was present in 33.2% of cases. Quadruple therapy for heart failure was initiated in the majority of patients before hospital discharge. The in-hospital mortality rate was 5.5%.</div></div><div><h3>Conclusion</h3><div>Acute heart failure in Mauritania primarily affects middle-aged individuals. The care follows the guidelines in the National Cardiology Center. A significant effort must be made to extend this organization to the rest of the country.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101914"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144570559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Limited data are available on cardiac manifestations in systemic lupus erythematosus (SLE) in Cameroon. The aim of this study was to report on electrocardiographic and echocardiographic abnormalities in this population.
Methods
A cross-sectional study was conducted from October 2023 to May 2024 at the Yaoundé Central Hospital, involving patients followed up for SLE satisfying the ACR/EULAR 2019 criteria, paired with healthy subjects. They underwent electrocardiographic and echocardiographic examinations. Frequencies of abnormalities were compared using Fisher's exact test. The significance threshold was 0.05.
Results
We included 55 SLE patients (94.5% female) with a mean age of 39 (10) years, and 55 matched control subjects. Clinically, 10 (18.2%) SLE patients presented with functional cardiac signs. Electrocardiographic and echographic abnormalities accounted for 29.1% and 43.6% of patients, respectively, with frequencies significantly higher than those of controls (10.9% and 7.3%, respectively). These included sinus tachycardia (14.5%), ST elevation (14.5%), and T-wave inversion (16.3%) on electrocardiography; pericardial effusion (25.5%), mitral insufficiency (23.6%), aortic insufficiency (20%), and pulmonary hypertension (14.5%) on echocardiography.
Conclusion
Electrocardiographic and echocardiographic abnormalities are common, affecting one-third and two-fifths respectively of SLE patients in our sample. They are usually asymptomatic, calling for screening and follow-up, as some can have a long-term prognostic impact.
{"title":"Anomalies électrocardiographiques et échocardiographiques au cours du lupus érythémateux systémique : les premières données des patients Camerounais","authors":"Jan René Nkeck , Valérie Ndobo-Koe , Stela Valdesse Kamgue Wambo , Carelle Doen Guedi , Adeline Pelda , Gisèle Flora Nandjip , Baudelaire Fojo , Caroline Ngoufack-Tientcheu , Blondelle Ndifon , Laeticia Yowo , Liliane Kuate Mfeukeu , Madeleine Ngandeu Singwé","doi":"10.1016/j.ancard.2025.101905","DOIUrl":"10.1016/j.ancard.2025.101905","url":null,"abstract":"<div><h3>Introduction</h3><div>Limited data are available on cardiac manifestations in systemic lupus erythematosus (SLE) in Cameroon. The aim of this study was to report on electrocardiographic and echocardiographic abnormalities in this population.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted from October 2023 to May 2024 at the Yaoundé Central Hospital, involving patients followed up for SLE satisfying the ACR/EULAR 2019 criteria, paired with healthy subjects. They underwent electrocardiographic and echocardiographic examinations. Frequencies of abnormalities were compared using Fisher's exact test. The significance threshold was 0.05.</div></div><div><h3>Results</h3><div>We included 55 SLE patients (94.5% female) with a mean age of 39 (10) years, and 55 matched control subjects. Clinically, 10 (18.2%) SLE patients presented with functional cardiac signs. Electrocardiographic and echographic abnormalities accounted for 29.1% and 43.6% of patients, respectively, with frequencies significantly higher than those of controls (10.9% and 7.3%, respectively). These included sinus tachycardia (14.5%), ST elevation (14.5%), and T-wave inversion (16.3%) on electrocardiography; pericardial effusion (25.5%), mitral insufficiency (23.6%), aortic insufficiency (20%), and pulmonary hypertension (14.5%) on echocardiography.</div></div><div><h3>Conclusion</h3><div>Electrocardiographic and echocardiographic abnormalities are common, affecting one-third and two-fifths respectively of SLE patients in our sample. They are usually asymptomatic, calling for screening and follow-up, as some can have a long-term prognostic impact.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 6","pages":"Article 101905"},"PeriodicalIF":0.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-09-20DOI: 10.1016/j.ancard.2025.101937
Sonia Corone , Romain Carpentier David , Christelle Pierre , Céline Chouhan , Titi Farrokhi , Aude Brucker , Romain Dorange , Pascal Guillo , Antoine Faure , Annie Fouard
Introduction
Despite the strong recommendations and obvious benefits, cardiac rehabilitation remains underutilised or is often discontinued in real‐world practice. To improve patient care, a hybrid (mix of home and centre) program (Read'Hy) has been developed, combining exercise training sessions and therapeutic education, with weekly face-to-face follow-up.
Methods
After a check-up and minimum five days initiation in the centre, patients returned home, equipped with a heart rate monitor and a mobile application. A personalised 10-week program was drawn up. Asynchronous home exercise was recorded and analysed daily by the rehabilitation technician. Each week, the patient came back to the centre for a supervised training session and interviews allowing to adjust the program.
Results
Out of 353 patients (mean age 55±11 years), 89% completed the program with 91% attendance and 35 physical activity sessions performed. Peak VO2 increased by 20% (21.8 to 26.1 ml/min/kg, p<0.0001), as did VO2 at point of intersection (16.6 to 19.9 ml/min/kg, p<0.0001) and maximum workload (140 to 168 Watts, p<0.0001). Only one rhythmic event was reported. Quality of life improved (VAS +14%, p<0.0001), and weekly physical activity quantified by IPAQ-SF increased by 53% (p<0.0001). After one year, IPAQ-SF remained 43.6% higher than the initial level (p<0.0001).
Conclusion
This hybrid program, both safe and effective, promotes the sustainable integration of physical activity into daily life.
{"title":"Experiment of Read’Hy : A hybrid, mix of home and centre, cardiac rehabilitation program","authors":"Sonia Corone , Romain Carpentier David , Christelle Pierre , Céline Chouhan , Titi Farrokhi , Aude Brucker , Romain Dorange , Pascal Guillo , Antoine Faure , Annie Fouard","doi":"10.1016/j.ancard.2025.101937","DOIUrl":"10.1016/j.ancard.2025.101937","url":null,"abstract":"<div><h3>Introduction</h3><div>Despite the strong recommendations and obvious benefits, cardiac rehabilitation remains underutilised or is often discontinued in real‐world practice. To improve patient care, a hybrid (mix of home and centre) program (Read'Hy) has been developed, combining exercise training sessions and therapeutic education, with weekly face-to-face follow-up.</div></div><div><h3>Methods</h3><div>After a check-up and minimum five days initiation in the centre, patients returned home, equipped with a heart rate monitor and a mobile application. A personalised 10-week program was drawn up. Asynchronous home exercise was recorded and analysed daily by the rehabilitation technician. Each week, the patient came back to the centre for a supervised training session and interviews allowing to adjust the program.</div></div><div><h3>Results</h3><div>Out of 353 patients (mean age 55±11 years), 89% completed the program with 91% attendance and 35 physical activity sessions performed. Peak VO<sub>2</sub> increased by 20% (21.8 to 26.1 ml/min/kg, <em>p</em><0.0001), as did VO<sub>2</sub> at point of intersection (16.6 to 19.9 ml/min/kg, <em>p</em><0.0001) and maximum workload (140 to 168 Watts, <em>p</em><0.0001). Only one rhythmic event was reported. Quality of life improved (VAS +14%, <em>p</em><0.0001), and weekly physical activity quantified by IPAQ-SF increased by 53% (<em>p</em><0.0001). After one year, IPAQ-SF remained 43.6% higher than the initial level (<em>p</em><0.0001).</div></div><div><h3>Conclusion</h3><div>This hybrid program, both safe and effective, promotes the sustainable integration of physical activity into daily life.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 5","pages":"Article 101937"},"PeriodicalIF":0.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号